| Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the … M Naghavi, KL Ong, A Aali, HS Ababneh, YH Abate, C Abbafati, ... The Lancet 403 (10440), 2100-2132, 2024 | 415 | 2024 |
| Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease … M Brauer, GA Roth, AY Aravkin, P Zheng, KH Abate, YH Abate, C Abbafati, ... The Lancet 403 (10440), 2162-2203, 2024 | 409 | 2024 |
| Global, regional, and national burden of disorders affecting the nervous system, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021 JD Steinmetz, KM Seeher, N Schiess, E Nichols, B Cao, C Servili, ... The Lancet Neurology 23 (4), 344-381, 2024 | 402 | 2024 |
| Burden of disease scenarios for 204 countries and territories, 2022–2050: a forecasting analysis for the Global Burden of Disease Study 2021 SE Vollset, HS Ababneh, YH Abate, C Abbafati, R Abbasgholizadeh, ... The Lancet 403 (10440), 2204-2256, 2024 | 178 | 2024 |
| Global, regional, and national burden of stroke and its risk factors, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021 VL Feigin, MD Abate, YH Abate, S Abd ElHafeez, F Abd-Allah, ... The Lancet Neurology 23 (10), 973-1003, 2024 | 70 | 2024 |
| Global, regional, and national incidence and mortality burden of non-COVID-19 lower respiratory infections and aetiologies, 1990–2021: a systematic analysis from the Global … RG Bender, SB Sirota, LR Swetschinski, RMV Dominguez, A Novotney, ... The Lancet Infectious Diseases, 2024 | 46 | 2024 |
| Contriving multi-epitope vaccine ensemble for monkeypox disease using an immunoinformatics approach S Aziz, FN Almajhdi, M Waqas, I Ullah, MA Salim, NA Khan, A Ali Frontiers in Immunology 13, 1004804, 2022 | 30 | 2022 |
| In silico prediction of novel inhibitors of SARS-CoV-2 main protease through structure-based virtual screening and molecular dynamic simulation SA Halim, M Waqas, A Khan, A Al-Harrasi Pharmaceuticals 14 (9), 896, 2021 | 29 | 2021 |
| GC-MS Analysis and Biomedical Therapy of Oil from n-Hexane Fraction of Scutellaria edelbergii Rech. f.: In Vitro, In Vivo, and In Silico Approach M Shah, W Murad, N Ur Rehman, S Mubin, JN Al-Sabahi, M Ahmad, ... Molecules 26 (24), 7676, 2021 | 27 | 2021 |
| Immunoinformatics design of multivalent epitope vaccine against monkeypox virus and its variants using membrane-bound, enveloped, and extracellular proteins as targets M Waqas, S Aziz, P Liò, Y Khan, A Ali, A Iqbal, F Khan, FN Almajhdi Frontiers in Immunology 14, 1091941, 2023 | 19 | 2023 |
| Novel 5-(Arylideneamino)-1H-Benzo[d]imidazole-2-thiols as Potent Anti-Diabetic Agents: Synthesis, In Vitro α-Glucosidase Inhibition, and Molecular Docking Studies S Ali, M Ali, A Khan, S Ullah, M Waqas, A Al-Harrasi, A Latif, M Ahmad, ... ACS omega 7 (48), 43468-43479, 2022 | 18 | 2022 |
| Forecasting the effects of smoking prevalence scenarios on years of life lost and life expectancy from 2022 to 2050: a systematic analysis for the Global Burden of Disease … D Bryazka, MB Reitsma, YH Abate, AHA Abd Al Magied, A Abdelkader, ... The lancet Public health 9 (10), e729-e744, 2024 | 17 | 2024 |
| Triazolothiadiazoles and triazolothiadiazines as potent α-glucosidase inhibitors: Mechanistic insights from kinetics studies, molecular docking and dynamics simulations S Ullah, M Waqas, SA Halim, I Khan, A Khalid, AN Abdalla, HA Makeen, ... International Journal of Biological Macromolecules 250, 126227, 2023 | 17 | 2023 |
| Identifying non-nucleoside inhibitors of RNA-dependent RNA-polymerase of SARS-CoV-2 through per-residue energy decomposition-based pharmacophore modeling, molecular docking … S Aziz, M Waqas, TK Mohanta, SA Halim, A Iqbal, A Ali, A Khalid, ... Journal of Infection and Public Health 16 (4), 501-519, 2023 | 16 | 2023 |
| Discovering novel inhibitors of P2Y12 receptor using structure-based virtual screening, molecular dynamics simulation and MMPBSA approaches SA Halim, M Waqas, A Asim, M Khan, A Khan, A Al-Harrasi Computers in Biology and Medicine 147, 105743, 2022 | 16 | 2022 |
| Identification of novel prolyl oligopeptidase inhibitors from resin of Boswellia papyrifera (Del.) Hochst. and their mechanism: Virtual and biochemical studies A Khan, M Waqas, M Khan, SA Halim, NU Rehman, A Al-Harrasi International Journal of Biological Macromolecules 213, 751-767, 2022 | 15 | 2022 |
| An Immunoinformatics Approach to Design a Potent Multi-Epitope Vaccine against Asia-1 Genotype of Crimean–Congo Haemorrhagic Fever Virus Using the Structural Glycoproteins as a … SZ Shah, B Jabbar, MU Mirza, M Waqas, S Aziz, SA Halim, A Ali, ... Vaccines 11 (1), 61, 2022 | 13 | 2022 |
| Molecular epidemiology of antibiotic-resistant genes and potent inhibitors against TEM, CTX-M-14, CTX-M-15, and SHV-1 proteins of Escherichia coli in district Peshawar, Pakistan N Rehman, S Azam, A Ali, M Asghar, M Ali, M Waqas, F Ullah, G e Sehra Saudi Journal of Biological Sciences 28 (11), 6568-6581, 2021 | 13 | 2021 |
| Multi-Fold Computational Analysis to Discover Novel Putative Inhibitors of Isethionate Sulfite-Lyase (Isla) from Bilophila wadsworthia: Combating Colorectal Cancer … M Waqas, SA Halim, A Ullah, AAM Ali, A Khalid, AN Abdalla, A Khan, ... Cancers 15 (3), 901, 2023 | 11 | 2023 |
| Exploring whole proteome to contrive multi-epitope-based vaccine for NeoCoV: An immunoinformtics and in-silico approach S Aziz, M Waqas, SA Halim, A Ali, A Iqbal, M Iqbal, A Khan, A Al-Harrasi Frontiers in Immunology 13, 956776, 2022 | 9 | 2022 |
Ahmed Al-HarrasiChair of Natural & Medical Sciences Research Center, University of NizwaVerified email at unizwa.edu.om